These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19710926)

  • 1. Side-alternating vibration training improves muscle performance in a patient with late-onset pompe disease.
    Khan A; Ramage B; Robu I; Benard L
    Case Rep Med; 2009; 2009():741087. PubMed ID: 19710926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side alternating vibration training in patients with mitochondrial disease: a pilot study.
    Newell C; Ramage B; Robu I; Shearer J; Khan A
    Arch Physiother; 2017; 7():10. PubMed ID: 29340204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term whole-body vibration training in two late-onset Pompe disease patients.
    Montagnese F; Thiele S; Wenninger S; Schoser B
    Neurol Sci; 2016 Aug; 37(8):1357-60. PubMed ID: 27193587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease.
    Chien YH; Hwu WL; Lee NC; Tsai FJ; Koeberl DD; Tsai WH; Chiu PC; Chang CL
    Mol Genet Metab Rep; 2017 Jun; 11():31-35. PubMed ID: 28480166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body vibration training improves flexibility, strength profile of knee flexors, and hamstrings-to-quadriceps strength ratio in females.
    Karatrantou K; Gerodimos V; Dipla K; Zafeiridis A
    J Sci Med Sport; 2013 Sep; 16(5):477-81. PubMed ID: 23253266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.
    Van den Hout JM; Kamphoven JH; Winkel LP; Arts WF; De Klerk JB; Loonen MC; Vulto AG; Cromme-Dijkhuis A; Weisglas-Kuperus N; Hop W; Van Hirtum H; Van Diggelen OP; Boer M; Kroos MA; Van Doorn PA; Van der Voort E; Sibbles B; Van Corven EJ; Brakenhoff JP; Van Hove J; Smeitink JA; de Jong G; Reuser AJ; Van der Ploeg AT
    Pediatrics; 2004 May; 113(5):e448-57. PubMed ID: 15121988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy.
    Terzis G; Dimopoulos F; Papadimas GK; Papadopoulos C; Spengos K; Fatouros I; Kavouras SA; Manta P
    Mol Genet Metab; 2011 Nov; 104(3):279-83. PubMed ID: 21640624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease.
    Jevnikar M; Kodric M; Cantarutti F; Cifaldi R; Longo C; Della Porta R; Bembi B; Confalonieri M
    Mol Genet Metab Rep; 2015 Dec; 5():67-71. PubMed ID: 28649546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exercise training during infusion on late-onset Pompe disease patients receiving enzyme replacement therapy.
    Terzis G; Krase A; Papadimas G; Papadopoulos C; Kavouras SA; Manta P
    Mol Genet Metab; 2012 Dec; 107(4):669-73. PubMed ID: 23146291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy.
    Lollert A; Stihl C; Hötker AM; Mengel E; König J; Laudemann K; Gökce S; Düber C; Staatz G
    PLoS One; 2018; 13(1):e0190784. PubMed ID: 29315315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body-vibration training increases knee-extension strength and speed of movement in older women.
    Roelants M; Delecluse C; Verschueren SM
    J Am Geriatr Soc; 2004 Jun; 52(6):901-8. PubMed ID: 15161453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of whole body vibration training on muscle strength and sprint performance in sprint-trained athletes.
    Delecluse C; Roelants M; Diels R; Koninckx E; Verschueren S
    Int J Sports Med; 2005 Oct; 26(8):662-8. PubMed ID: 16158372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Muscle Strength and Walking Performance in Adult Patients With Pompe Disease.
    Favejee MM; van der Meijden JC; Kruijshaar ME; Rizopoulos D; van der Ploeg AT; Bussmann JBJ
    Phys Ther; 2018 Nov; 98(11):925-931. PubMed ID: 30265367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole body vibration improves maximum voluntary isometric contraction of knee extensors in patients with chronic kidney disease: A randomized controlled trial.
    Fuzari HK; Dornelas de Andrade A; A Rodrigues M; I Medeiros A; F Pessoa M; Lima AM; Cerqueira MS; Marinho PE
    Physiother Theory Pract; 2019 May; 35(5):409-418. PubMed ID: 29482412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the patient-reported outcomes measurement information system (PROMIS®) to assess late-onset Pompe disease severity.
    Harfouche M; Kishnani PS; Krusinska E; Gault J; Sitaraman S; Sowinski A; Katz I; Austin S; Goldstein M; Mulberg AE
    J Patient Rep Outcomes; 2020 Oct; 4(1):83. PubMed ID: 33034771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise training alone or in combination with high-protein diet in patients with late onset Pompe disease: results of a cross over study.
    Sechi A; Zuccarelli L; Grassi B; Frangiamore R; De Amicis R; Marzorati M; Porcelli S; Tullio A; Bacco A; Bertoli S; Dardis A; Biasutti L; Pasanisi MB; Devigili G; Bembi B
    Orphanet J Rare Dis; 2020 Jun; 15(1):143. PubMed ID: 32505193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: Prospective analysis from the French Pompe Registry.
    Semplicini C; De Antonio M; Taouagh N; Béhin A; Bouhour F; Echaniz-Laguna A; Magot A; Nadaj-Pakleza A; Orlikowski D; Sacconi S; Salort-Campana E; Solé G; Tard C; Zagnoli F; Hogrel JY; Hamroun D; Laforêt P;
    J Inherit Metab Dis; 2020 Nov; 43(6):1219-1231. PubMed ID: 32515844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Whole-Body-Vibration Training on Trunk-Muscle Strength and Physical Performance in Healthy Adults: Preliminary Results of a Randomized Controlled Trial.
    Maeda N; Urabe Y; Sasadai J; Miyamoto A; Murakami M; Kato J
    J Sport Rehabil; 2016 Dec; 25(4):357-363. PubMed ID: 27632856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive association between physical outcomes and patient-reported outcomes in late-onset Pompe disease: a cross sectional study.
    Yuan M; Andrinopoulou ER; Kruijshaar ME; Lika A; Harlaar L; van der Ploeg AT; Rizopoulos D; van der Beek NAME
    Orphanet J Rare Dis; 2020 Sep; 15(1):232. PubMed ID: 32883321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vibration therapy tolerated in children with Duchenne muscular dystrophy: a pilot study.
    Myers KA; Ramage B; Khan A; Mah JK
    Pediatr Neurol; 2014 Jul; 51(1):126-9. PubMed ID: 24830767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.